fbpx Back to Top

Amyloidosis

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Amyloidosis fund is currently closed. As of November 13, 2018, The Assistance Fund’s Hereditary Amyloidosis fund is accepting applications.

Assistance Amount

$7,800 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for amyloidosis.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level. 
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Actemra (tocilizumab)
  • Active Injection Kit D (dexamethasone sodium phosphate/pf)
  • Alferon N (interferon alfa-n3)
  • Alkeran (melphalan)
  • Astagraf Xl (tacrolimus)
  • Betamethasone Acetate-Sod Phos (betamethasone acetate and sodium phos in sterile water/pf)
  • Bortezomib (bortezomib)
  • Colchicine (colchicine)
  • Colcrys (colchicine)
  • Cyclophosphamide (cyclophosphamide)
  • Decadron (dexamethasone)
  • Dexamethasone Acetate La (dexamethasone acetate in sodium chloride, iso-osmotic)
  • Dexamethasone Intensol (dexamethasone)
  • Dexamethasone-0.9% Nacl (dexamethasone sodium phosphate in 0.9 % sodium chloride)
  • Dexpak (dexamethasone)
  • Dexycu (dexamethasone/pf)
  • Dmt Suik (dexamethasone/pf/norflurane/pentafluoropropane (hfc 245fa))
  • Doubledex (dexamethasone sodium phosphate/pf)
  • Enbrel (etanercept)
  • Envarsus Xr (tacrolimus)
  • Evomela (melphalan hcl/betadex sulfobutyl ether sodium)
  • Humira (adalimumab)
  • Humira Pediatric Crohn'S (adalimumab)
  • Ilaris (canakinumab/pf)
  • Inflectra (infliximab-dyyb)
  • Intron A (interferon alfa-2b,recomb.)
  • Kineret (anakinra)
  • Lidocidex-I (dexamethasone sodium phosphate/lidocaine hcl)
  • Locort (dexamethasone)
  • Mas Care-Pak (dexamethasone sodium phosphate/pf)
  • Melphalan Hcl (melphalan hcl)
  • Mitigare (colchicine)
  • Ozurdex (dexamethasone)
  • Pomalyst (pomalidomide)
  • Prograf (tacrolimus)
  • Protopic (tacrolimus)
  • Remicade (infliximab)
  • Renflexis (infliximab-abda)
  • Revlimid (lenalidomide)
  • Tacrolimus (tacrolimus)
  • Taperdex (dexamethasone)
  • Thalomid (thalidomide)
  • Velcade (bortezomib)
  • Zodex (dexamethasone)
  • Zonacort (dexamethasone)
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Diagnosis Codes:

ICD-10: E85.0, E85.1, E85.81,  E85.82, E85.89, E85.2-E85.4, E85.8, E85.9

Related Organizations: